Anmeldung Registrierung
Auto Hell Dunkel
Erweiterte Suche
  1. Startseite
  2. Podcasts
  3. Tierärztliche Fakultät - Digitale Hochschulschriften der LMU - Teil 03/07 Podcast
  4. Hyperthermie zur tumorgerichteten Therapie mit Liposomen und Gentransferkomlexen im Tiermodell
Despite various approaches of cancer treatment, side effects due to
the missing tumour selectivity are still dose limiting and result
in inefficient therapy outcome. Local hyperthermia of tumour tissue
is crucial to increase the efficiency of common therapies and
already made its way to clinical application. To further increase
efficiency and specificity of antitumoural treatments and to
decrease toxicity, thermosensitive carriers with a phase transition
temperature designed for hyperthermic applications were developed.
After systemic application of thermosensitive PVP-polyplexes in
Neuo2A tumour bearing mice combined with hyperhermia treatment a
significantly higher and more selective gene expression was found
in hyperthermia treated tumours. Combination of PVP10-polyplexes
and hyperthermia showed a high specifity on tumours whereas the
treatment was less efficent compared to systemic application of
PVP10 without hyperthermia. Furthermore, efficiency and specificity
correlated with tumor size, showing higher but less specific
reporter gene expression in larger tumours. Histology showed that
PVP-polyplexes are associated to tumour endothelium which probably
decreased the uptake into the tumour tissue and resulted in lower
efficiency. In conclusion, despite established non viral gene
transfer polyplexes the evaluated PVP-polyplexes are remarkably
specific when combined with hyperthermia. Further experiments are
on their way to enlighten the mechanism of thermosensitive
polyplexes and to optimise efficiency of treatment. To determine
the effect of hyperthermia on clinically used chemotherapeutics
BFS-1 tumour bearing mice were treated with liposomal and free
doxorubicin at hyperthermic and normothermic conditions. No effect
on tumour growth was observed by hyperthermia alone. The
combination of free doxorubicin with hyperthermia showed a
synergistic effect and resulted in a significant tumour growth
delay compared to chemotherapy alone or controls. Hyperthermia
increases the efficiency of free doxorubicin via changing the
physiological properties of tumour tissue. However, liposomal
doxorubicin out rated the hyperthermia effect due to increased
plasma circulation time. Nevertheless hyperthermia is a promising
approach to increase the efficiency of chemotherapeutic drugs. An
in vivo toxicity study of liposomal HePC did not show any side
effects. Because of HePC integration into the lipid membrane a
systemic application of the usually haemolytic drug is possible.
After the treatment with HePC-TSL and hyperthermia a significant
increase of HePC concentration was found in hyperthermia treated
tumours. However, due to low drug levels or study design no effect
on tumour growth was detected. Further studies will focus on the
addition of hydrophilic drugs within the core of HePC-TSL and
therefore enrich two synergistic drugs in hyperthermia treated
tumor tissue. The development of thermosensitive carriers might be
a very promising improvement of cancer treatment. Combined with
hyperthermia those carriers result in a specific, local enrichment
of drugs in targeted tissues.
Episode melden

„Hyperthermie zur tumorgerichteten Therapie mit Liposomen und Gentransferkomlexen im Tiermodell“

Worum geht es? Danach fragen wir noch nach dem Grund.

Abonnenten

Teilen

Mein Archiv

Deine Privatkopie der Folgen, die du nicht verlieren willst.

Podcast-Folgen verschwinden. Feeds werden auf die letzten Episoden gekürzt, Hoster räumen alte Dateien ab, Formate wechseln den Anbieter und lassen ihr Archiv zurück. Mit „Mein Archiv“ sichert podcast.de die Folgen deiner Podcasts für dich — angefangen bei den ältesten, denn die sind zuerst weg.

  • Deine gesicherten Folgen bleiben hörbar, auch wenn das Original offline geht.
  • Auch Folgen, die im heutigen Feed gar nicht mehr stehen — podcast.de kennt sie noch.
  • Herunterladen bleibt möglich, solange die Folge beim Podcaster liegt. Der zählt seine Abrufe wie bisher.
Startet bald

Sei beim Start von Mein Archiv dabei

Mein Archiv ist fast fertig. Trag dich ein, dann bekommst du eine E-Mail, sobald es losgeht – und bist von Anfang an dabei. Wir schreiben dir nur zum Start, keine Werbung, keine Weitergabe deiner Daten.

Du bekommst zuerst eine Bestätigungsmail. Abmelden geht jederzeit. Datenschutz